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A floating thrombus within the aortic arch is a rare condition that is generally detected after cerebral, visceral, or
peripheral embolization. Endovascular exclusion of suchmobile thrombus has been described but exclusively involved the
descending aorta, or debranching of the supra-aortic trunk was done by open surgical bypass procedure. We present a case
with a floating thrombus that extended throughout the whole aortic arch and involved all of the supra-aortic trunks. The
pathology was treated by debranching the supra-aortic trunks using a new nonsutured Viabahn-based (W. L. Gore &
Associates, Flagstaff, Ariz) technique (ViabahnOpen Revascularization TEChnique [VORTEC]) for revascularization of
the left common carotid artery and performing an antegrade endograft implantation from the ascending aorta, distal to
the origin of the feeding graft for debranching, to the descending aorta in one procedure. (J Vasc Surg 2009;50:
1177-80.)A floating thrombus within the aortic arch is a rare
condition that is generally detected after cerebral, visceral,
or peripheral embolization.1 Endovascular exclusion of
such mobile thrombus has already been described,2-8 but
exclusively involved the descending aorta2-7; or debranch-
ing of the supraaortic trunk was done by open surgical
bypass procedure.8 We present a patient with a floating
thrombus that extended throughout the whole aortic arch
and involved all of the supraaortic trunks. The pathology
was treated by debranching the supra-aortic trunks using a
new nonsutured Viabahn-based (W. L. Gore & Associates,
Flagstaff, Ariz) technique (Viabahn Open Revasculariza-
tion TEChnique [VORTEC]) for revascularization of the
left common carotid artery (LCCA) and performing an
antegrade endograft implantation from the ascending
aorta, distal to the origin of the feeding graft for debranch-
ing, to the descending aorta in one procedure.
CASE REPORT
Patient. A 59-year-old woman was referred to our university
center due to a progressive floating thrombus within the aortic
arch. She underwent transbrachial thrombectomy 4months before
for acute brachial ischemia and was treated since then with Cou-
madin (Bristol-Myers Squibb, Princeton, NJ). Periodic coldness of
the left hand was the only residual symptom, and the patient was
neurologically asymptomatic.
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doi:10.1016/j.jvs.2009.05.052A thoracoabdominal computed tomography (CT) angiogra-
phy (CTA) showed thrombus extending from the proximal aortic
arch and floating downstream into the descending aorta (Fig 1).
The thrombus pedicle involved the brachiocephalic trunk and
extended within the LCCA and the left subclavian artery, which
were completely or partially occluded (Fig 2).
Cardiac history and investigation revealed no arrhythmia, isch-
emic heart disease, valvular disease, or intracardiac thrombus. Results
of tumor screening were negative, but the preoperative cerebral CT
scan revealed two asymptomatic lesions of unknown origin in the
posterior semioval center. ColorDoppler ultrasound imaging showed
minimal stenosis of internal carotid arteries, occlusion of the left
vertebral, and normal antegrade perfusion of the right vertebral arter-
ies. The only positive finding was positive level of activated phospho-
lipid antibody (lupus anticoagulant) and low levels of protein S and
protein C, suggesting a probable antiphospholipid syndrome.
Owing to the unknown origin of the two cerebral tumors, it
was decided to avoid an arch procedure under circulatory arrest,
which would put the patient at risk for cerebral bleeding. Revas-
cularization of the left subclavian artery was not considered neces-
sary because the occlusion was chronic and asymptomatic. Further-
more, the left vertebral artery was also occluded by the distal
extension of the thrombus.
Procedure. The supra-aortic vessels were approached through
a full-length median sternotomy. The brachiocephalic trunk and
LCCA were carefully dissected with a no-touch technique approxi-
mately 3 cm distal to their origin. Simultaneously, a bifurcated graft
was tailored to the patient’s anatomy ex vivo to serve as a feeding graft
for the debranching procedure. For this purpose, to a 10-mm ex-
panded polytetrafluoroethylene (ePTFE) graft (W. L. Gore & Asso-
ciates) was sewn a 6-mm ring-supported ePTFE side-branch graft
(FlowLine Bipore, JOTEC, GmbH, Hechinger, Germany).
After systemic heparinization (100 IU/kg), the aorta was
partially clamped with a side-biter clamp, and the proximal end of
the 10-mm feeding graft was sutured end-to-side to the ascending
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rotic lesions proven by preoperative CTA. The LCCA was revas-
cularized using the VORTEC technique.9
Briefly, after puncturing the anterior wall of the LCCA in a
thrombus-free area, a 7-mm Viabahn endograft was introduced
over the wire (Seldinger technique) approximatively 2 cm into the
LCCA through the origin of the 6-mm interposition side-branch
graft (IG). The running suture anastomosis between the feeding
and the branched graft for LCCA was constructed ex vivo. The
running suture was not knotted, and the Viabahn stent graft was
introduced over the wire into the LCCA through an 8F sheath.
After Viabahn deployment and ballooning, removal of the
sheath, and retrograde and antegrade flushing, the running suture
was knotted and blood flow into the LCCAwas resumed. The total
ischemia time of LCCA was 2 minutes (during Viabahn deploy-
ment and balloon inflation). No cerebral protection technique was
used. The Viabahn endograft was then fixed to the LCCAwith two
transmural polypropylene 6-0 sutures. Finally, the origin of the
brachiocephalic trunk and the proximal LCCA were interrupted
with a ligature and the distal end of the 10-mm feeding graft was
Fig 1. Thoracic CT angiography. The sagittal CT reconstruction
shows the thrombus pedicle (white arrow) originating on the level
of the brachiocephalic trunk (***) and extending to the proximal
descending aorta. The floating part of the thrombus projects into
the aorta at the level of the left subclavian artery (*). The origin of
the brachiocephalic trunk is circumferentially narrowed. The left
common carotid artery (**) is near totally occluded and the left
subclavian artery is totally occluded (including the origin of the left ver-
tebral artery). The proximal descending aorta is involved with the
disease.anastomosed end-to-side to the brachiocephalic trunk.Access for the antegrade stent graft insertion was achieved as
recently described.10 A 24F sheath was introduced into the ascend-
ing aorta, just distally to the debranching graft by gentle manipu-
lation and constant transesophageal echocardiography (TEE) con-
trol. A 28-mm (15-cm in length) TAG endograft (W. L. Gore &
Associates) was introduced and deployed. No thrombus dislodge-
ment was detected on TEE during endograft placement. Postpro-
cedural CTA, performed immediately after surgery, did not detect
any perfusion deficits (Fig 3).
The patient’s postoperative course was uneventful. She was
asymptomatic and was discharged 7 days after the procedure.
Combination therapy with a platelet inhibitor (aspirin, 300 mg)
and Coumadin, which was started immediately after the interven-
tion, was administered. A CTA at discharge showed no brain
damage. Stereotactic biopsy of the two brain tumors 2 months
later showed a partially coagulated and partially nonorganized
hematoma, without any sign of malignancy. Unfortunately, the
patient died 5 days after the brain tumor biopsy with signs of a
massive myocardial infarct. Permission for postmortem examina-
tion could not be obtained.
DISCUSSION
A thrombus, generally developing secondarily to an
atherosclerotic plaque,11 located within the aortic arch, is
rare (0.08%).12 Extensive endoaortic thrombosis can be
observed in patients with primary hematologic disor-
ders11,13 such as antiphospholipid syndrome, paraneoplas-
tic coagulation disorder, aspergillosis,14 and long-term
treatment with steroids.15 A floating thrombus is defined as
a nonadherent part of the thrombus floating within the
aortic lumen. The natural history of such floating thrombus
is not well known. Clinical presentation ranges from asymp-
tomatic disease to symptoms related to cerebral, peripheral,
or visceral embolization.12 Embolization of nonfloating
and floating thrombus is reported in 12% and 75% of
Fig 2. Thoracic CT angiography. CT slice and sagittal recon-
struction showing the thrombus extension within the supraaortic
vessels (BCT: brachiocephalic trunk, LCCA: left common carotid
artery, LSA: left subclavian artery).patients, respectively.16
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scribed.Medical treatment (anticoagulation, thrombolysis)
may lead to complete dissolution of the thrombus in most
patients. However, embolization remains the major con-
cern with this approach.1 Thrombectomy, thromboendar-
terectomy, and aortic replacement carry a high morbidity,
mainly due to cerebral complications occurring in up to
29% of the patients.17
Surgery requires careful analysis of CTA, which has
replaced TEE as the diagnostic modality and planning tool
of choice.3-7 Before any VORTEC procedure, we carefully
analyze the CTA studies and reconstructions to detect
potential problems and plan for the optimal puncture site.
In this patient, the thrombus extended from the aortic arch
within the first 2 cm of LCCA origin. However, 10 cm of
nonaltered LCCA was left from the distal end of thrombus
to the carotid bifurcation, which was sufficient for a safe
puncture above the thrombosed area of the LCCA, inser-
tion of the guidewire (approximately 3 to 4 cm), catheter,
and finally, the Viabahn stent graft in the LCCA.
The use of cerebral protection techniques needs to be
clarified. We did not use any distal protection technique
during Viabahn stent graft deployment in this patient. Our
experience has led us to conclude that additional protection
Fig 3. Postoperative CT angiography. The 3D reconstructions
show the supraaortic debranching and the endograft extending
from proximal to the origin of the brachiocephalic trunk to the
mid-descending aorta.techniques are not necessary and may even be harmful bycomplicating the procedure, resulting in potential dissec-
tions, prolonged ischemia time, or access problems. Fur-
thermore, the diameter of the deployed Viabahn stent graft
is wider than that of the target vessel, so that the thrombus
is trapped between the Viabahn and the inner wall of the
artery.
Why was the VORTEC procedure in this young patient
preferred instead of suturing the distal end of the 6-mm
graft to the LCCA? We presumed that open surgery in this
obese patient (BMI 30.3) with a hostile, short neck would
require more extensive LCCA dissection, thereby increas-
ing the risk for embolization. In addition, the ischemia time
for open surgery would have been significantly longer than
that for the VORTEC procedure. We were concerned that
after complete cross-clamp of LCCA during open bypass
surgery, ischemia-reperfusion injury might result in sec-
ondary bleeding within the two lesions of unknown origin.
Criado et al2 reported the first use of an endograft to
cover a recurrent floating thrombus located in the descend-
ing aorta. In their case, surgical thrombectomy had been
performed 1 month earlier.2 Since then, several authors
have reported their experience with endograft implanta-
tion.2-8 In all but one8 of these patients, treatment was
limited to the descending aorta,2-7 and inmost patients, the
proximal landing zone of the endograft was located distal
to the left subclavian artery and never crossed the LCCA. In
our patient, endovascular exclusion of the arch thrombus
required coverage of the entire arch (ascending aorta to
descending aorta), necessitating a preliminary debranching
of the supra-aortic vessels.
The hybrid debranching and endovascular approach is
a less invasive option than open surgery. It can also be
applied to treat simultaneously lesions of the thoracic and
abdominal aorta.6 Although the risk of accidental emboli-
zation seems to be low, it can probably not be eliminated
completely, even with antegrade endograft implantation.
Debranching the supra-aortic vessels, including interrup-
tion of the normal anatomical inflow from the arch before
any endovascular manipulation within the aortic arch, elim-
inates cerebral embolization associated with endovascular
manipulations. Antegrade endograft introduction and de-
ployment through the ascending aorta reduces the risk of
embolization compared with crossing the lesion in a retro-
grade manner with wires or devices that have limited flexi-
bility. If embolization occurs, surgical embolectomy or
thrombus aspiration can be performed3 with usual tech-
niques. A drawback of our technique is the inability to
obtain material for histologic examination. However, this
can be done by obtaining thrombus material by aspiration
biopsy through the aortic wall or by opening the aneurysm
sack once the endograft has been deployed.
Clear recommendations regarding anticoagulation reg-
imens to be used before and after endograft exclusion of
mobile thrombus of the thoracic aorta are missing. Reports
of seven patients have been published. Anticoagulation was
used in three patients to avoid thrombus progression and
embolization.1,2,6 Two3,5 of the seven patients2-8 did not
receive anticoagulation before the intervention. Some re-
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endografting, oral anticoagulation was administered to all
but one patient4 receiving clopidogrel. One case report did
not mention anticoagulation.8 In our patient, with suspi-
cion of antiphospholipid syndrome, long-term combina-
tion therapy with aspirin and Coumadin was used.
To our knowledge, this is the first case description of
hybrid treatment of a floating arch thrombus by VORTEC
debranching, a sutureless anastomosis technique that po-
tentially reduces the risk of cerebral embolization.
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